CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Alameda Health System

Mark Amey, Chief Information Officer

Safeguarding People Irrespective of Caste, Creed and Color

Mark Amey

Mark Amey

A strange thing happened on the way to dealing with COVID-19…


We learned that you can’t fight a new pandemic with old thinking and reluctant action —particularly those grounded in low expectations of our consumers and maybe even racism.


As an IT leader, I’ve shepherded Alameda Health System’s deployment of its electronic health record. Before the implementation, we were asked, “is it the right time? Will our population of vulnerable, homeless and low-income families be able to take advantage of its technology?”


Interestingly, when implementing electronic health records at other systems that served a more “sophisticated” population, those questions were never asked.


We know that there are disparities in health care. The most devastating may be a disparity in expectations.


If we fail to give disadvantaged populations the information, tools, and resources to better manage their health, we doom them to poor health outcomes – and ultimately – to a premature demise. COVID-19 reaffirmed that people of color suffering from social determinants of health and limited access to care are killed by COVID-19 at a disproportionate rate.


The need to protect patients and staff from exposure to the coronavirus forced us to overcome prejudice and implicit bias. Lengthy pondering about a faraway vision of more excellent connectivity and alternative methods of care delivery were replaced by immediate action. In a matter of weeks, if not days, we rallied to create telemedicine visits to maintain primary care appointments and other services. We stopped asking if we should. The question was, what if we don’t?


The answer was that more black and brown people, particularly those from low-income communities that depend upon safety net systems for care, would be placed at higher risk if required to come to facilities for care. Many of our patients suffer from limited access to transportation, and some take hour-long bus rides to arrive at our clinics. Can you imagine a patient risking exposure to COVID-19 on mass transportation as we urge folks to practice social distancing for a primary care check-up?


Some still asked if our patients would need help to become more computer literate.


My wonderful 70-something mother is fighting cancer. She adores her provider, but to “see” her involves a two-hour car ride, plus an exhausting 1/8 a mile hike once parked because she can’t afford the expensive parking near the provider’s practice. That reality changes when we offer telehealth.


We embraced technology sooner than we would have otherwise and made our technology simple by going to where the consumer is. Within days of CDC’s social distancing guidance, we put the wheels in motion to raise fully-operational isolation tents, created a work from home environment for hundreds – and thousands, if needed. We created an electronic dashboard to allow us real-time visibility into our COVID patients and trends by race, ethnicity, and zip code sooner so we can flatten disparities more quickly than not.


We stood up a telehealth program, enhanced our culture of safety – and we did it all without compromise to the quality of care. We customized the technology for the patients. Within a few weeks, we doubled/tripled the number of remote visits. Our patients have loved it, and the system is better off for it.


Battling COVID-19 showed me that gaps in our expectations fuel pandemics and allow them to spread like wildfire through populations we under-serve, under-mind, and under-resource. Technology shared broadly, can be a bridge that helps close a sizable gap in access to care and disparities in outcomes.


I am humbled. Never before did I imagine that the very thing I’ve built my life and career – can serve as a bridge that helps close a sizeable gap in access to care and disparities in outcomes.


COVID-19 provided a wake-call. It’s up to us to remove our bias and get out of technology’s way.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/leadership-perspective/mark-amey-nwid-2978.html